Latest filing published 29 Sept 2021 for C4 Therapeutics, Inc., €23k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Elena Prokupets: trading record in brief
Elena Prokupets, listed as board member, appears in our data through filings on C4 Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 6 October 2020 to 27 September 2021, the count stands at 30 filings.
No open-market purchase appears, only 28 sales worth €7.3M. Since January 2021: no purchases and 28 sales on the market.
On 29 September 2021 came the latest disclosure, an open-market sale for €56k in C4 Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Elena Prokupets
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 539 shares@ US$50.03531.6% of flowCommon StockSEC:0001209191-21-058111:0
- 3,544 shares@ US$50.1010.5% of flowCommon StockSEC:0001209191-21-057633:0
- 5,152 shares@ US$50.040415.2% of flowCommon StockSEC:0001209191-21-057118:0
- 492 shares@ US$50.00691.4% of flowCommon StockSEC:0001209191-21-056482:0
- 1,230 shares@ US$50.00083.6% of flowCommon StockSEC:0001209191-21-055886:0
- 14,407 shares@ US$45.157738.0% of flowCommon StockSEC:0001209191-21-050057:0
- 11,336 shares@ US$45.004229.7% of flowCommon StockSEC:0001209191-21-049118:0
7 of 7 declarations
